Efficacy and safety of a new selective class III antiarrhythmic agent dofetilide in paroxysmal atrial fibrillation or atrial flutter

Am J Cardiol. 1992 Feb 1;69(4):417-9. doi: 10.1016/0002-9149(92)90247-v.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Anti-Arrhythmia Agents / adverse effects
  • Anti-Arrhythmia Agents / therapeutic use*
  • Atrial Fibrillation / drug therapy*
  • Atrial Flutter / drug therapy*
  • Blood Pressure
  • Dose-Response Relationship, Drug
  • Electrocardiography
  • Female
  • Humans
  • Male
  • Middle Aged
  • Phenethylamines / adverse effects
  • Phenethylamines / therapeutic use*
  • Sulfonamides / adverse effects
  • Sulfonamides / therapeutic use*
  • Tachycardia, Paroxysmal / drug therapy*

Substances

  • Anti-Arrhythmia Agents
  • Phenethylamines
  • Sulfonamides
  • dofetilide